Across its top 15 institutional holders, RKDA's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 16/100, avg. turnover score 30/100).

Quarterly Activity

Recent Activity

+$445.8K

Total Buy Value

$174.0

Total Sell Value

New buy3

Trim0

Add3

Sold out3

Net Buyers

Net Sellers

Smart Money Convergence

RKDA does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.

13F data as of 2026-03-31 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/RKDA

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

Filings (14d)

Data as of 2026-07-02

2026-07-02

Arcadia Biosciences disclosed on July 1, 2026 that its board approved a $169,000 discretionary cash bonus for CEO Thomas J. Schaefer for the 2025 year. The company had previously stated in its amended annual report that it would file an 8-K when the bonus amount was determined. No other named executive officers received a bonus for 2025.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

CUSIP

039014303

FAQ

Who are the top institutional investors holding ARCADIA BIOSCIENCES INC (RKDA)?

Major stakeholders currently include Armistice Capital, LLC ($220.0K), Sabby Management, LLC ($158.1K), Geode Capital Management, LLC ($43.8K). Based on the latest 13F filings, there are a total of 15 tracked investment funds and institutions maintaining positions in RKDA.

What is the overall institutional sentiment toward RKDA recently?

Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $404.7K, driven by 6 managers accumulating shares while 3 reduced their exposure.

Which institutions have been selling or reducing their RKDA positions?

In the latest period, 0 funds trimmed their holdings, and 3 managers completely exited their positions. The aggregate reported sell value was $174.0.

Are there any notable investors adding RKDA to their portfolios?

Yes, buying activity remains notable. 3 institutions opened new positions in {ticker}, and 3 existing holders added to their shares. The total reported buy value for the quarter amounted to $445.8K.

Related Stocks

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,151

Total reported value

$2.1T

3246 13F institutions increased their position this quarter

View detail

AMZN

Amazon.com INC

Institutions Holding

5,958

Total reported value

$1.5T

3029 13F institutions increased their position this quarter

View detail

NVDA

Nvidia CORP

Institutions Holding

5,766

Total reported value

$3.0T

2744 13F institutions increased their position this quarter

View detail

Developer Access

Access RKDA's institutional ownership data programmatically:

REST API

curl https://alphasmo.com/api/v1/market/stock/RKDA

CLI

npx alphasmo stocks get RKDA

Full API & MCP documentation →